Pasithea Therapeutics Corp. Quarterly report [Sections 13 or 15(d)]

Stock Options (Tables)

3 Months Ended

Mar. 31, 2026

Stock option activity for the three months ended March 31, 2026, was as follows:

	Number of Options		Weighted average exercise price per share		Weighted average remaining contractual term (years)		Aggregate intrinsic value (in thousands)
Outstanding, January 1, 2026		1,685,843	$	2.77		9.60
Granted		-	$	-		-	$	-
Expired/Cancelled		-	$	-		-
Outstanding, March 31, 2026		1,685,843	$	2.77		9.36	$	-

Exercisable, March 31, 2026		129,857	$	26.13		7.06